VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Early Out who wrote (7466)	4/26/1998 1:40:00 PM
From: James Baker	Read Replies (1) of 23519

jsc: Since Viagra is not approved except in America, and I assume MUSE is approved around the world, then it stands to reason that this week's script numbers should be higher for MUSE, no? Not higher than Viagra obviously, but I mean higher than for previous week's for MUSE itself. Now, if I were a betting man I'd say the numbers will be lower>>>>>>> John, IMS AMERICA reports, would you believe, US RX data and NOT worldwide data. So yes the MUSE NEW RX numbers will be down as everyone tries a shot with Viagra. It will be after V failure and recognition that there are other treatments worth the effort to try if men are serious about treating moderate to severe ED that MUSE new and refill RX numbers will again pick up. The interval here is yet to be determined. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next